Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 1,751–1,780 of 1,780 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05373251	PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer(PATH)	not yet recruiting	N/A	500	British Columbia Cancer AgencyOTHER	0	May 13, 2022	clinicaltrials
NCT04437329	Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma	recruiting	Phase 3	352	Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER	1	May 10, 2022